Antifungal agents in current pediatric practice

Cecinati Valerio; Teresa Perillo; Letizia Brescia; Fabio Giovanni Russo

doi:10.1007/s11908-013-0337-1

Antifungal agents in current pediatric practice

Cecinati Valerio, Teresa Perillo, Letizia Brescia, Fabio Giovanni Russo

Ospedale Pediatrico Bambino Gesu

Research output: Contribution to journal › Article

Abstract

Invasive fungal infections are an important cause of morbidity and mortality in immunocompromised children. Increases in the incidence of systemic mycoses have been observed during the last 2 decades. Treatment of invasive fungal infections has improved through a better knowledge and application of current treatment strategies and through the development of new antifungal compounds. The purpose of this review is to provide antifungal treatment recommendations for pediatric patients that can help clinicians find the most suitable treatment for each specific case.

Original language	English
Pages (from-to)	278-287
Number of pages	10
Journal	Current Infectious Disease Reports
Volume	15
Issue number	3
DOIs	https://doi.org/10.1007/s11908-013-0337-1
Publication status	Published - Jun 2013

Keywords

Antimycotic drugs
Children
Fungal infections

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1007/s11908-013-0337-1

Fingerprint Dive into the research topics of 'Antifungal agents in current pediatric practice'. Together they form a unique fingerprint.

Cite this

Valerio, C., Perillo, T., Brescia, L., & Russo, F. G. (2013). Antifungal agents in current pediatric practice. Current Infectious Disease Reports, 15(3), 278-287. https://doi.org/10.1007/s11908-013-0337-1

@article{ecdce6ae50384cb1a32f80ecf03c3a60,

title = "Antifungal agents in current pediatric practice",

abstract = "Invasive fungal infections are an important cause of morbidity and mortality in immunocompromised children. Increases in the incidence of systemic mycoses have been observed during the last 2 decades. Treatment of invasive fungal infections has improved through a better knowledge and application of current treatment strategies and through the development of new antifungal compounds. The purpose of this review is to provide antifungal treatment recommendations for pediatric patients that can help clinicians find the most suitable treatment for each specific case.",

keywords = "Antimycotic drugs, Children, Fungal infections",

author = "Cecinati Valerio and Teresa Perillo and Letizia Brescia and Russo, {Fabio Giovanni}",

year = "2013",

month = jun,

doi = "10.1007/s11908-013-0337-1",

language = "English",

volume = "15",

pages = "278--287",

journal = "Current Infectious Disease Reports",

issn = "1523-3847",

publisher = "Current Science, Inc.",

number = "3",

}

TY - JOUR

T1 - Antifungal agents in current pediatric practice

AU - Valerio, Cecinati

AU - Perillo, Teresa

AU - Brescia, Letizia

AU - Russo, Fabio Giovanni

PY - 2013/6

Y1 - 2013/6

N2 - Invasive fungal infections are an important cause of morbidity and mortality in immunocompromised children. Increases in the incidence of systemic mycoses have been observed during the last 2 decades. Treatment of invasive fungal infections has improved through a better knowledge and application of current treatment strategies and through the development of new antifungal compounds. The purpose of this review is to provide antifungal treatment recommendations for pediatric patients that can help clinicians find the most suitable treatment for each specific case.

AB - Invasive fungal infections are an important cause of morbidity and mortality in immunocompromised children. Increases in the incidence of systemic mycoses have been observed during the last 2 decades. Treatment of invasive fungal infections has improved through a better knowledge and application of current treatment strategies and through the development of new antifungal compounds. The purpose of this review is to provide antifungal treatment recommendations for pediatric patients that can help clinicians find the most suitable treatment for each specific case.

KW - Antimycotic drugs

KW - Children

KW - Fungal infections

UR - http://www.scopus.com/inward/record.url?scp=84878740646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878740646&partnerID=8YFLogxK

U2 - 10.1007/s11908-013-0337-1

DO - 10.1007/s11908-013-0337-1

M3 - Article

C2 - 23616182

AN - SCOPUS:84878740646

VL - 15

SP - 278

EP - 287

JO - Current Infectious Disease Reports

JF - Current Infectious Disease Reports

SN - 1523-3847

IS - 3

ER -